Necrotizing Enterocolitis Risk State of the Science

被引:185
作者
Gephart, Sheila M. [1 ]
McGrath, Jacqueline M. [3 ]
Effken, Judith A. [1 ]
Halpern, Melissa D. [2 ]
机构
[1] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA
[2] Univ Arizona, Steele Childrens Res Ctr, Tucson, AZ 85721 USA
[3] Virginia Commonwealth Univ, Sch Nursing, Richmond, VA 23284 USA
关键词
necrotizing enterocolitis; neonatal; nursing; risk assessment; risk profile; BIRTH-WEIGHT INFANTS; DONOR HUMAN-MILK; PREMATURE-INFANTS; PROBIOTICS; EPIDEMIOLOGY; METAANALYSIS; EXPOSURE; FORMULA; IMPACT; TRIAL;
D O I
10.1097/ANC.0b013e31824cee94
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Necrotizing enterocolitis (NEC) is the most common cause of gastrointestinal-related morbidity and mortality in the neonatal intensive care unit (NICU). Its onset is sudden and the smallest, most premature infants are the most vulnerable. Necrotizing enterocolitis is a costly disease, accounting for nearly 20% of NICU costs annually. Necrotizing enterocolitis survivors requiring surgery often stay in the NICU more than 90 days and are among those most likely to stay more than 6 months. Significant variations exist in the incidence across regions and units. Although the only consistent independent predictors for NEC remain prematurity and formula feeding, others exist that could increase risk when combined. Awareness of NEC risk factors and adopting practices to reduce NEC risk, including human milk feeding, the use of feeding guidelines, and probiotics, have been shown to reduce the incidence of NEC. The purpose of this review is to examine the state of the science on NEC risk factors and make recommendations for practice and research.
引用
收藏
页码:77 / 87
页数:11
相关论文
共 84 条
  • [61] Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants
    Morgan, J.
    Young, L.
    McGuire, W.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [62] National Institute of Child Health and Human Development, 2006, COMM REFL TREATM LIN
  • [63] Necrotizing Enterocolitis Guideline Team Cincinnati Children's Hospital Medical Center, 2010, EV BAS CAR GUID NECR, V28, P1
  • [64] A roadmap for understanding and preventing necrotizing enterocolitis
    Neu J.
    Mshvildadze M.
    Mai V.
    [J]. Current Gastroenterology Reports, 2008, 10 (5) : 450 - 457
  • [65] Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/713605804
  • [66] Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants
    Ohlsson, Arne
    Walia, Rajneesh
    Shah, Sachin S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (04):
  • [67] Virtual elimination of necrotising enterocotitis for 5 years - reasons?
    Patole, S
    McGlone, L
    Muller, R
    [J]. MEDICAL HYPOTHESES, 2003, 61 (5-6) : 617 - 622
  • [68] Prevention and treatment of necrotising enterocolitis in preterm neonates
    Patole, Sanjay
    [J]. EARLY HUMAN DEVELOPMENT, 2007, 83 (10) : 635 - 642
  • [69] Patole SK, 2000, INT J CLIN PRACT, V54, P429
  • [70] Impact of standardised feeding regimens on incidence of neonatal necrotising enterocolitis: a systematic review and meta-analysis of observational studies
    Patole, SK
    de Klerk, N
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2005, 90 (02): : 147 - 151